Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
22 Cards in this Set
- Front
- Back
What types of non-ob surgery does pregnant pt's undergo?
|
trauma, cervical cerclage, appy, biliary, breast, ovarian, cystectomy
|
|
List special concerns for surgery in the pregnant patient:
|
physiological changes, teratogenicity of drugs, urteroplacental blood flow, increased risk for PTL, IUGR, fetal demise
|
|
List characteristics of drugs that cross the placenta:
|
high lipophilicity, low ionization, low maternal protein binding, low molecular weight
|
|
How are placental transfer and fetal uptake of a drug measured?
|
ratio of umbilical vein to maternal venous concentration (UV/MV) = degree of transfer of drug;
ratio of umbilical artery to umbilical vein (UA/UV) = fetal uptake of drug |
|
Is the timing of exposure to a drug important?
|
Yes, risk is highest during organogensesis (2-8weeks gestation); drugs prior to implantation <1week gestation insignificant; exposure late in pregnancy =functional/behavioral changes
|
|
When should non-ob surgery be done on the pregnant patient?
|
second trimester; cervical cerclage is usually done at 12-16weeks gestation
|
|
Name 8 concerns when planning surgery for an OB patient:
|
1. Decreased MAC
2. Decreased FRC 3. Increased metabolic rate 4. Slowed GI emptying 5. Teratogenicity 6. Maintenance of uteroplacental circulation 7. Increased Risk Preterm Labor 8. Need to monitor FHR |
|
How would you premedicate a pregnant patient for non-ob surgery?
|
Bicitra, H2 antagonist, metoclopramide, barbiturate, glycopyrrolate
|
|
Misc. perioperative concerns:
|
Keep maternal PaCO2 at 30torr (the PaCO2-EtCO2 gradient is reduced d/t decreased dead space ventilation-perfusion from increased CO); Avoid alpha agonists, high levels of LA, & catecholamines, avoid hypoglycemia
|
|
Special considerations appendectomy:
|
increased incidence pulmonary edema-careful fluid management
|
|
Special considerations Neurosurgery:
|
induced hypotension = decreased UPP; hyperventilation shifts dissociation curve to the left and decreeases O2 released to fetus, high dose mannitol can cause fetal dehydration
|
|
Special considerations laparoscopic surgery:
|
keep intraabdominal pressure <15torr, elevated paCO2 = fetal acidosis; on Varess needle
|
|
Special considerations cardiac surgery:
|
usually for valvular dx, avoid high dose vasopressors = decreased UPP
|
|
Special considerations for trauma:
|
Increased maternal CO may lead to underestimation of hemorrhage; preterm labor, premature rupture of membranes, uterine rupture, placental abruption, spontanous AB
|
|
How is cardiac arrest managed in the parturient?
|
Standard BLS/ACLS guidelines with avoidance of aortocaval compression, emergency c-section at >24-25weeks gestation
|
|
Indications for emergent c-section in traumatic event:
|
stable mother with viable fetus in distress; traumatic uterine rupture; gravid uterus interfering with intraabdominal repair; unsalvageable mother with viable fetus
|
|
What are the relative advantages of GA vs. regional in traumatic/non-ob surgery?
|
GA: inhalation agents are tocolytics
Regional: decreased risk of aspiration, possible increased risk of hypotension **Priority is to maintain maternal oxygenation & UPP |
|
Is N20 safe in pregnant patients?
|
N2O shown in animals to vasoconstrict the uterine arteries when not administered with volatile agent (not shown in humans)
|
|
Does N2O increase the risk of congenital defects?
|
In rats shown, not in humans; inactivates Vit. B12, inhibits methionine synthetase & potentially interfers with DNA synthesis; Conservative approach-use 50% N2O during organogenesis, limit use in longer cases
|
|
Can benzodiazapines be used in pregnant patients?
|
Case reports of cleft palates in children, but failed to find in studies
|
|
Are there special considerations in patient monitoring of non-ob surgery, pregnant patients?
|
FHR, uterine activity pre, intra, & post-op; Loss of beat to beat variability is normal after anesthetic medications, but decelerations are NOT expected; atropine can cause decreased beat to beat variability and fetal tachycardia
|
|
Which medications are most likely to pass into breast milk?
|
Highly lipid soluble
Poorly protein bound |